Literature DB >> 8553361

Structure activity relationships in skin sensitization using the murine local lymph node assay.

J Ashby1, D A Basketter, D Paton, I Kimber.   

Abstract

Murine local lymph assay node data for 106 chemicals are listed. Among these, 73 are active in the assay indicating their potential as skin sensitizing agents. Broad structure activity relationships (SAR) are suggested based on the electrophilic theory of skin sensitization suggested by Landsteiner and Jacobs in 1936, and elaborated by Dupuis and Benezra in 1982. Eight classes of agent are discerned; electrophiles, potential electrophiles after metabolism, Michael-reactive agents, benzoylating agents, ionic chemicals and miscellaneous agents. The electrophilic theory cannot at present fully explain the activity of agents in the last two classes. That fact will hopefully focus research into their mode of action. Some chemicals fit equally into more than one class, and such agents are entered into the several classes in order not to bias the analysis. Attention is given to why not all chemicals of a class are active in the assay. It is concluded that a combination of inappropriate lipophilicity, molecular size and metabolic detoxification are responsible for these inactivities. Given a sufficient number of analogues tested within each class it should be possible eventually to predict with accuracy the skin sensitizing potential of new members of the class. However, the present analysis is qualitative, not quantitative. Finally, the parallelism between sensitizing potential and mutagenic potential for chemicals is explored further.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8553361     DOI: 10.1016/0300-483x(95)03132-y

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  8 in total

1.  Predicting allergic contact dermatitis: a hierarchical structure-activity relationship (SAR) approach to chemical classification using topological and quantum chemical descriptors.

Authors:  Subhash C Basak; Denise Mills; Douglas M Hawkins
Journal:  J Comput Aided Mol Des       Date:  2008-03-13       Impact factor: 3.686

2.  Perspectives on Non-Animal Alternatives for Assessing Sensitization Potential in Allergic Contact Dermatitis.

Authors:  Nripen S Sharma; Rohit Jindal; Bhaskar Mitra; Serom Lee; Lulu Li; Tim J Maguire; Rene Schloss; Martin L Yarmush
Journal:  Cell Mol Bioeng       Date:  2012-03       Impact factor: 2.321

3.  Correlating the structure and reactivity of a contact allergen, DNCB, and its analogs to sensitization potential.

Authors:  Flora Kimani; Seong-Min Kim; Rachel Steinhardt; Aaron P Esser-Kahn
Journal:  Bioorg Med Chem       Date:  2019-05-11       Impact factor: 3.641

4.  A genomic biomarker signature can predict skin sensitizers using a cell-based in vitro alternative to animal tests.

Authors:  Henrik Johansson; Malin Lindstedt; Ann-Sofie Albrekt; Carl A K Borrebaeck
Journal:  BMC Genomics       Date:  2011-08-08       Impact factor: 3.969

5.  Relationship between allergic contact dermatitis and electrophilicity.

Authors:  H S Rosenkranz; G Klopman; Y P Zhang; C Graham; M H Karol
Journal:  Environ Health Perspect       Date:  1999-02       Impact factor: 9.031

6.  FAF-Drugs3: a web server for compound property calculation and chemical library design.

Authors:  David Lagorce; Olivier Sperandio; Jonathan B Baell; Maria A Miteva; Bruno O Villoutreix
Journal:  Nucleic Acids Res       Date:  2015-04-16       Impact factor: 16.971

7.  Determination of Protein Haptenation by Chemical Sensitizers Within the Complexity of the Human Skin Proteome.

Authors:  Erika Parkinson; Maja Aleksic; Richard Cubberley; Gushinder Kaur-Atwal; Johannes P C Vissers; Paul Skipp
Journal:  Toxicol Sci       Date:  2018-04-01       Impact factor: 4.849

8.  Interpretation of murine local lymph node assay (LLNA) data for skin sensitization: Overload effects, danger signals and chemistry-based read-across.

Authors:  David W Roberts
Journal:  Curr Res Toxicol       Date:  2021-01-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.